Minutes of Meeting
Title : Meeting regarding cooperation between Indian Pharmacopoeia Commission (IPC), National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) and Indian Medical Association (IMA) to promote the patient safety in the country
Date : 6th January 2016 Time: 3.30 pm onwards
Venue : O/o DCG(I),Central Drugs Standard Control Organization (CDSCO), FDA Bhawan, New Delhi.
Attendance:
|
S.No. |
Name |
Designation |
|
1. |
Dr. G. N. Singh |
Drugs Controller General (India)& Secretary-cum-Scientific Director, IPC |
|
2. |
Dr. S. S. Agarwal |
President, IMA |
|
|
Dr. K. K. Agarwal |
Honorary Secretary General, IMA |
|
4. |
Dr. Ramesh Datta |
Joint Secretary, IMA |
|
5. |
Dr. R. N. Tandon |
Honorary Finance Secretary, IMA |
|
6. |
Dr. Manjul Mehta |
Assistant Secretary, IMA |
|
7 |
Dr. V. K. Monga |
Dean of Studies-Elect, IMA CGP |
|
8 |
Ms. A. Visala |
|
|
9 |
Dr. Mita Nandy |
Consultant, CDSCO |
|
10 |
Dr. Kalaiselvan |
Principal Scientific Officer, IPC |
|
11 |
Dr. Prasad Thota |
Scientific Assistant, IPC |
|
12 |
Sh. Varun Chopra |
Technical Associate, IPC |
Background
A meeting regarding cooperation between Indian Pharmacopoeia Commission (IPC), National Coordination Centre (NCC) for Pharmacovigilance Programme of India (PvPI) and Indian Medical Association (IMA) to promote the patient safety in the country was held on 6th January 2016 at CDSCO Hq, FDA Bhawan, New Delhi.
IPC, NCC-PvPI and Indian Medical Association (IMA) mutually agreed to work together to promote the patient safety in the country.
Letter of Intent for Cooperation
A Letter of Intent for cooperation was signed between IPC, NCC-PvPI and IMA on 6th January 2016. Dr. G. N. Singh, DCG(I) &Secretary-cum-Scientific Director, IPC and Dr. S. S. Agarwal, President, IMA signed the Letter of Intent for cooperation on behalf of IPC and IMA respectively and exchanged the same.
Expected Outcome
NCC-PvPI and IMA agreed to cooperate for the following areas:
- PvPI-IMA patient safety monitoring cell to be started at IMA Head Quarter in the designated space provided by IMA.
- Organising Continuing Medical Educations (CMEs), disseminating PvPI information/concept of Pharmacovigilance (PV) in IMA in News, Journals etc.
- IMA to identify the nodal centres for education/ advocacy and ADR monitoring and recommend to NCC-PvPI for recognition.
- Training to the nodal coordinators/medical officers.
- Development/up-gradation of Mobile app. for ADR monitoring.
- A “National Day on Patient Safety” is to be celebrated by NCC-PvPI and IMA in collaboration.
- Other areas to promote patient safety.
Dr. G. N. Singh, DCG(I) & Secretary-cum-Scientific Director, IPC (Right) and Dr. S. S. Agarwal, President, IMA (Left) signing and exchanging the Letter of Intent.